America’s Health Insurance Plans today released findings from a study assessing health insurance claims from 2009 to 2013 on six recommendations from the Centers for Disease Control and Prevention’s Guideline for Prescribing Opioids for Chronic Pain. According to AHIP, the vast majority of opioid prescriptions for chronic pain were for immediate-release opioids, consistent with CDC recommendations, but certain other measures could be improved. For example, about one-quarter of opioid prescriptions were above the CDC-recommended morphine milligram equivalent dosage, the organization said. The study methodology has been shared with insurance providers nationwide, who may apply it to measure their own opioid prevention and management efforts.

Related News Articles

Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA and other national hospital organizations Sept. 5 urged Senate and House leadership to act on preventing Medicaid Disproportionate Share Hospital…
Perspective
Public
Congress returns to Washington, D.C., this week facing a long list of things to do, including several that will impact hospitals’ ability to provide access to…
Headline
The Department of Health and Human Services Sept. 4 announced new hardship exemption guidance that would allow consumers ineligible for premium tax credits or…
Headline
The Centers for Medicare & Medicaid Services Innovation Center Sept. 2 announced changes to the Achieving Healthcare Efficiency through Accountable Design…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…